Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center – Trademark Portfolio

Entity Type: 99

Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The owner is based in Cleveland, OH.

2500 1 Emery Road, Suite 150

Cleveland, OH 44128

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CORDHEAL
CORDHEAL
Abandoned 2019
CORDTREG
CORDTREG
Abandoned 2019
CORDHEAL
CORDHEAL
Abandoned 2016

Trademark Classifications

Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center have?

Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center has 3 U.S. trademarks filed with the USPTO.

What trademark classes does Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center file in?

Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center's trademark registration success rate?

Abraham J and Phyllis Katz Cord Blood Foundation d/b/a Cleveland Cord Blood Center has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.